Harlan Pinto
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Member, Stanford Cancer Institute
- Associate Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
Key Documents
Contact Information
-
Clinical Offices
Medical Oncology 875 Blake Wilbur Dr Clinic B MC 5820 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-9113
- Academic Offices
Personal Information Email Tel (650) 493-5000 ext. 64948 Tel (650) 858-3931Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Head and Neck Cancer
- Medical Oncology
- Head and Neck Cancer
- Oncology
Professional Education
| Residency: | Massachusetts General Hospital MA (1986) |
| Fellowship: | Stanford University School of Medicine CA (1991) |
| Internship: | Massachusetts General Hospital MA (1984) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (1991) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1986) |
| Medical Education: | Yale University School of Medicine-Graduate CT (1983) |
Scientific Focus
Current Research Interests
Clinical investigations focus on head and neck cancer with a particular interest in combined modality therapy. Through the Stanford University Head and Neck Tumor Board, clinical trials are conducted which involve all aspects of care for patients with head and neck cancer. The clinical research program includes translation of preclinical work performed in the Radiobiology Section at Stanford, new drug development, the development of novel combination therapy, chemoprevention, and the integration of biological response modifiers into combined modality treatment.
As a member of Stanfords Eastern Cooperative Oncology Group trials effort, Dr. Pinto is involved in the implementation and development of a variety of clinical trials at Stanford and the Palo Alto Veterans Affairs Medical Center.
Publications
- Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head Neck. 2011; (1): 103-11
- Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2010; (5): 1339-46
- Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008; (2): 393-400
- Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; (4): 261-9
- In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2008; (4): 1151-7
- Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007: 58S-67S
Help